Latest Earnings Results: Q2 '26
Estimated EPS
$0.06
Reported EPS
$0.10
Surprise
+72.58%
Estimated Rev
$830.03M
Reported Rev
$848.9M
Surprise
+2.27%
• Reported GAAP EPS of -$0.12 down -500.00% YoY • Reported revenue of $848.9M up 2.75% YoY • Surgery Partners reaffirmed its full year 2026 revenue guidance in the range of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million, excluding the pending Idaho Falls divestiture.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $0.11 | -- | -- | N/A |
Q2 '26 | $0.06 | $0.10 | 72.58% | BEAT |
Q1 '26 | -$0.12 | -$0.03 | 75.90% | BEAT |
Q4 '25 | $0.30 | $0.12 | -60.55% | MISSED |
Q3 '25 | $0.20 | $0.13 | -35.92% | MISSED |